Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Northwest Biotherapeutics (NWBO) Shares Outstanding (Diluted) (2009 - 2026)

Updated

Northwest Biotherapeutics (NWBO) posted Weighted Average Shares Outstanding (Diluted) of 1.64 billion for Q2 2026, up 14.2% from 1.44 billion a year earlier and up 3.6% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends

For FY2025, Northwest Biotherapeutics' Weighted Average Shares Outstanding (Diluted) came in at 1.46 billion, up 17.3% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for 12 consecutive years, with a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
  • In prior years, Northwest Biotherapeutics' Weighted Average Shares Outstanding (Diluted) was 1.24 billion in FY2024 (+11.0%), 1.12 billion in FY2023 (+10.2%), 1.02 billion in FY2022 (+0.8%) and 1.01 billion in FY2021 (+39.0%).
  • The Q2 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q3 2010.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last eight quarters, with growth averaging 16.0% over the last eight quarters.
  • The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q3 2021, with growth of 47.1%; the weakest was Q1 2023, with a decline of 99.9%.
  • According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 1.58 billion (Q1 2026), 1.46 billion (Q4 2025) and 1.43 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Northwest Biotherapeutics 283.78 Mn 273.80 Mn - 1.64 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.64 Bn
Mar 31, 2026 1.58 Bn
Dec 31, 2025 1.46 Bn
Sep 30, 2025 1.43 Bn
Jun 30, 2025 1.44 Bn
Mar 31, 2025 1.36 Bn
Dec 31, 2024 1.24 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 1.12 Bn
Dec 31, 2023 1.12 Bn
Sep 30, 2023 1.11 Bn
Jun 30, 2023 1.11 Mn
Mar 31, 2023 1.07 Mn
Dec 31, 2022 1.02 Bn
Sep 30, 2022 1.04 Bn
Jun 30, 2022 1.00 Bn
Mar 31, 2022 1.01 Bn
Dec 31, 2021 1.01 Bn
Sep 30, 2021 1.10 Bn
API Access

Northwest Biotherapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NWBO&period=max&api_key=YOUR_API_KEY